Lundberg Sven Ante
Insider CIK 1682126 · MRUS President, CEO & PFO, Director · QTTB Director · CRSP Chief Scientific Officer · VOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-07-21 | 10,826 | — | $0 | 10,826 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-06-12 | 2026-06-16 | 9,810 | — | $0 | 9,810 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2026-01-15 | 2026-01-30 | 20,363 | $2.75 | $56.0K | 20,363 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 312,620 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 351,628 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 300,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 360,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 380,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 295,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 16,372 | $97.00 | $1.59M | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 30,297 | $97.00 | $2.94M | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 9,192 | $97.00 | $891.6K | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 9,192 | $97.00 | $891.6K | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 9,191 | $97.00 | $891.5K | 0 | SEC↗ |
| MRUS Merus N.V. | U Tender | 2025-12-12 | 2025-12-12 | 9,191 | $97.00 | $891.5K | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 14,198 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 12,215 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 2,539 | — | $0 | 9,192 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 30,297 | — | $0 | 30,297 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 30,297 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 52,369 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 22,449 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 24,229 | — | $0 | 16,372 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 2,538 | — | $0 | 9,191 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 2,539 | — | $0 | 9,191 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-11-25 | 2025-11-28 | 2,539 | — | $0 | 9,192 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-10-23 | 2025-10-27 | 53,521 | — | $0 | 53,521 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2025-04-17 | 2025-04-21 | 3,797 | $12.54 | $47.6K | 0 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2025-04-17 | 2025-04-21 | 26,500 | $13.52 | $358.3K | 312,620 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2025-04-17 | 2025-04-21 | 3,797 | $12.54 | $47.6K | 3,797 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2025-04-17 | 2025-04-21 | 26,500 | $13.52 | $358.3K | 30,297 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 12,767 | — | $0 | 12,767 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 2,013 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 23,140 | — | $0 | 23,140 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 23,140 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 1,316 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 2,013 | — | $0 | 2,013 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 12,767 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 2,880 | — | $0 | 2,880 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 2,880 | — | $0 | 0 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 6,238 | — | $0 | 6,238 | SEC↗ |
| QTTB Q32 Bio Inc. | D To issuer deriv | 2025-02-24 | 2025-02-26 | 6,238 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-02-19 | 2025-02-21 | 40,601 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2025-02-19 | 2025-02-21 | 40,601 | — | $0 | 40,601 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2025-02-13 | 2025-02-18 | 16,372 | — | $0 | 351,628 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2025-02-13 | 2025-02-18 | 16,372 | $24.43 | $400.0K | 40,601 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-01-29 | 2025-01-31 | 300,000 | — | $0 | 300,000 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2025-01-15 | 2025-02-26 | 23,140 | — | $0 | 23,140 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-09-25 | 2024-09-27 | 1,316 | — | $0 | 1,316 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 360,000 | — | $0 | 360,000 | SEC↗ |
| QTTB Q32 Bio Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 12,767 | — | $0 | 12,767 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-02-02 | 2023-02-03 | 380,000 | — | $0 | 380,000 | SEC↗ |
| MRUS Merus N.V. | P Buy | 2022-11-03 | 2022-11-03 | 14,706 | $14.38 | $211.5K | 40,576 | SEC↗ |
| MRUS Merus N.V. | P Buy | 2022-08-22 | 2022-08-23 | 5,826 | $22.92 | $133.5K | 25,870 | SEC↗ |
| MRUS Merus N.V. | P Buy | 2022-08-19 | 2022-08-22 | 704 | $22.99 | $16.2K | 20,044 | SEC↗ |
| MRUS Merus N.V. | P Buy | 2022-07-12 | 2022-07-13 | 4,340 | $22.97 | $99.7K | 19,340 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-01-31 | 2022-02-02 | 295,000 | — | $0 | 295,000 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2021-08-02 | 2021-08-04 | 12,627 | $13.52 | $170.7K | 339,120 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2021-08-02 | 2021-08-04 | 2,373 | $12.54 | $29.8K | 3,797 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2021-08-02 | 2021-08-04 | 2,373 | $12.54 | $29.8K | 15,000 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2021-08-02 | 2021-08-04 | 12,627 | $13.52 | $170.7K | 12,627 | SEC↗ |
| MRUS Merus N.V. | G Gift | 2021-03-25 | 2021-03-29 | 74,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 63,170 | — | $0 | 351,747 | SEC↗ |
| MRUS Merus N.V. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 10,830 | — | $0 | 6,170 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2021-03-01 | 2021-03-03 | 63,170 | $13.52 | $854.1K | 74,000 | SEC↗ |
| MRUS Merus N.V. | M Exercise | 2021-03-01 | 2021-03-03 | 10,830 | $12.54 | $135.8K | 10,830 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-02-16 | 2021-02-18 | 368,000 | — | $0 | 368,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2021-02-05 | 2021-02-09 | 16,900 | — | $0 | 16,900 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2020-01-03 | 2020-01-06 | 414,917 | — | $0 | 414,917 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion deriv | 2016-10-24 | 2017-02-10 | 55,217 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | P Buy | 2016-10-24 | 2017-02-10 | 400 | $14.00 | $5.6K | 505,617 | SEC↗ |
| CRSP CRISPR Therapeutics AG | C Conversion | 2016-10-24 | 2017-02-10 | 55,217 | — | $0 | 505,217 | SEC↗ |